Sarah Davidson

Clinical Project Coordinator
Consultancies and Vendor Staff

Sarah joined the Therapeutic Vaccine Research Program at Kirby Institute in 2018 after more than 10 years working in Clinical Haematology Research. Sarah currently manages a research project investigating whether DNA incorporation of azacitidine derivatives in mononuclear cells is higher following 21 days of oral azacitidine than following 7 days of Vidaza® in a 28 day treatment cycle.